Ikena Oncology Stock Price on April 15, 2021
| IKNA Stock | USD 1.28 0.05 3.76% |
If you're considering investing in Ikena Stock, it is important to understand the factors that can impact its price. As of today, the current price of Ikena Oncology stands at 1.28, as last reported on the 16th of April 2024, with the highest price reaching 1.36 and the lowest price hitting 1.26 during the day. Ikena Oncology holds Efficiency (Sharpe) Ratio of -0.0799, which attests that the entity had a -0.0799% return per unit of risk over the last 3 months. Ikena Oncology exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Ikena Oncology's Standard Deviation of 4.63, risk adjusted performance of (0.07), and Market Risk Adjusted Performance of (0.36) to validate the risk estimate we provide.
At present, Ikena Oncology's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 54.2 M, whereas Common Stock is forecasted to decline to about 26.6 K. . At present, Ikena Oncology's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.51, whereas Price To Sales Ratio is forecasted to decline to 8.53. Ikena Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Ikena |
Sharpe Ratio = -0.0799
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IKNA |
Estimated Market Risk
| 4.66 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ikena Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ikena Oncology by adding Ikena Oncology to a well-diversified portfolio.
Price Book 0.3781 | Enterprise Value Ebitda 1.3514 | Price Sales 7.0069 | Shares Float 17.9 M | Wall Street Target Price 8.33 |
Ikena Oncology Valuation on April 15, 2021
It is possible to determine the worth of Ikena Oncology on a given historical date. On April 15, 2021 Ikena was worth 6.19 at the beginning of the trading date compared to the closed value of 6.05. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ikena Oncology stock. Still, in general, we apply an absolute valuation method to find Ikena Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ikena Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ikena Oncology's related companies.
| Open | High | Low | Close | Volume | |
04/01/2022 | 6.19 | 6.24 | 5.78 | 6.05 | 83,400 |
| 6.05 | 6.30 | 5.94 | 6.19 | 62,400 |
| Backtest Ikena Oncology | | | Ikena Oncology History | | | Ikena Oncology Valuation | Next |
Ikena Oncology Trading Date Momentum on April 15, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Ikena Oncology Fundamentals Correlations and Trends
By evaluating Ikena Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ikena Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ikena financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ikena Oncology Stock history
Ikena Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ikena is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ikena Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ikena Oncology stock prices may prove useful in developing a viable investing in Ikena Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 41.7 M | 40.8 M | |
| Net Loss | -61.9 M | -65 M |
Ikena Oncology Quarterly Net Working Capital |
|
Ikena Oncology Stock Technical Analysis
Ikena Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ikena Oncology Period Price Range
Low | April 1, 2022
| High |
6.19 | 6.05 |
Ikena Oncology April 16, 2024 Market Strength
Market strength indicators help investors to evaluate how Ikena Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ikena Oncology shares will generate the highest return on investment. By undertsting and applying Ikena Oncology stock market strength indicators, traders can identify Ikena Oncology entry and exit signals to maximize returns
| Accumulation Distribution | 6148.08 | |||
| Daily Balance Of Power | (0.30) | |||
| Rate Of Daily Change | 0.98 | |||
| Day Median Price | 6.01 | |||
| Day Typical Price | 6.02 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (4.77) |
Ikena Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ikena Oncology's price direction in advance. Along with the technical and fundamental analysis of Ikena Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ikena to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (0.97) | |||
| Treynor Ratio | (0.37) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ikena Oncology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Ikena Stock refer to our How to Trade Ikena Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Ikena Stock analysis
When running Ikena Oncology's price analysis, check to measure Ikena Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ikena Oncology is operating at the current time. Most of Ikena Oncology's value examination focuses on studying past and present price action to predict the probability of Ikena Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ikena Oncology's price. Additionally, you may evaluate how the addition of Ikena Oncology to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Ikena Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ikena Oncology. If investors know Ikena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ikena Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.63) | Revenue Per Share 0.219 | Quarterly Revenue Growth (0.88) | Return On Assets (0.26) | Return On Equity (0.43) |
The market value of Ikena Oncology is measured differently than its book value, which is the value of Ikena that is recorded on the company's balance sheet. Investors also form their own opinion of Ikena Oncology's value that differs from its market value or its book value, called intrinsic value, which is Ikena Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ikena Oncology's market value can be influenced by many factors that don't directly affect Ikena Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ikena Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ikena Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ikena Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.